This set included genes already reported in the literature as differentially expressed in pancreatic cancer and that have been investigated as biomarkers for pancreatic cancer (i.e. S100A6 [47], S100P [46], TIMP1 [63] and NF-κB [64]). This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.